Objective It has recently been reported that 18 
Introduction

Pancreatic cancer is one of the most difficult diseases to detect and treat early in its progression. Although by worldwide consensus the best therapy for pancreatic cancer is surgical resection, unresectable cases have been treated with various methods, including chemotherapy
, radiotherapy (2) , chemoradiotherapy (3, 4) and immunotherapy (5, 6) . with pancreatic cancer or for early estimation of the effects of chemotherapy (12) and radiotherapy (13) .
Recently, studies have reported the effectiveness of chemotherapy with gemcitabine (GEM) alone or in combination T a b l e 1 . Ch a r a c t e r i s t i c s o f 1 9 P a t i e n t s
All of these studies illustrate the benefit of FDG-PET, however, this imaging modality is not necessarily useful in every situation. The aim of this study was to clarify the effectiveness of FDG-PET in evaluating the response to therapeutic interventions, especially chemotherapy, for pancreatic cancer. We treated patients with unresectable pancreatic cancer using GEM and S-1, and we evaluated the tumor response to this chemotherapeutic regimen using FDG-PET, CT, and serum tumor markers (TMs).
Patients and Methods
Patients
The study population consisted of 19 T h e r e wa s n o s i g n i f i c a n t d i f f e r e n c e b e t we e n t h e t wo g r o u p s ( l o g -r a n k t e s t ； p = 0 . 5 9 ) . 
Best tumor response
This was defined as the best tumor response through all courses (!2 courses) as assessed by any of the three modalities (CT, PET and TMs), assuming the response was either PR or CR for each modality. For example, assuming the patient received four courses of chemotherapy, if the patient exhibited SD via PET after the 1st course, SD after the 2nd course, CR after the 3rd course, and PR after the 4th course, the best tumor response via PET throughout the four courses was CR, achieved after the 3rd course using PET.
Statistical analysis
Survival analysis was performed using the Kaplan 
Results
Patient characteristics and survival
Characteristics of the 19 patients are shown in Table 1 
FDG-PET, TM, and CT responses
T a b l e 2 . F DG-P E T , T M a n d CT Re s p o n s e s a n d S u r v i v a l T i me s
Characteristics of subgroups classified by survival times
We 
07). In indexes of the three modalities (FDG-PET, TM and CT), SUV of the pancreatic lesion alone showed a significant difference between the ST!12 and ST<12 groups (p<0.05). However, there was no significant difference between survival of the low SUV group (< 4.5) (n=9, MST: 12.5 months) and that of the high SUV group (!4.5) (n=10, MST: 10.2 months) (Table 2).
There were four patients (cases 4, 10, 11, and 12) Fig. 2A, B ( Fig. 2C) . Figure 3 indicates that the better the best tumor response as assessed by PET or TM, the better the prognosis of the patients (Fig. 3A, B) . On the other hand, no difference in prognosis was found based on CT assessment of the best tumor response (Fig. 3C) . (cases 1, 4, 12, 16, 17, 19) or two courses (cases 3, 11) (es- Table 3 (Fig. 4) . Meanwhile, although the changes of SUVs for many TM responders also indicated an early decrease of that within one course (cases 1, 3, 4, 10, 11, 19) , SUVs of two cases (cases 12 and 17) were reduced at late phase.
in this study who survived for more than 15 months (Table 2). All of them presented with PET-PR or TM-PR after 1 course (2 cases, PET-PR with TM-PR; 1 case, PET-PR; and 1 case, TM-PR). Both PET and TM assessed best tumor responses as CR, via PET in all patients and also via TM in 3. No patient who survived for fewer than 15 months exhibited PET-CR or TM-CR. In CT evaluation, all four cases presented with SD after 1 course; for two of those cases the best response was PR, while for the other two it was SD.
Survival times of subgroups classified by chemotherapy results
Figure 2 shows the survival curves of subgroups divided by tumor response after 1 course of chemotherapy. Although PET-PR and TM-PR groups presented with good prognosis [MST of PET responders, 12.5 months (95% CI, 10.1-14.9), MST of TM responders, 15.8 months (95% CI, 12.6-19.0)] (
), there was no significant difference between survival times of the subgroups. Moreover, the prognosis of the CT-PR group (MST, 10.3 months) was worse than that of the CT-SD group [MST, 15.8 months (95% CI, 9.6-22.0)]
F i g u r e 2 . S u r v i v a l c u r v e s f o r p a t i e n t s c a t e g o r i z e d b y mo d a l i t y [ F DG-P E T ( A) , T M ( B ) a n d CT ( C) ] a n d f u r t h e r g r o u p e d b y P R, S D, a n d P D a t f o u r we e k s ( 1 c o u r s e ) a f t e r t h e s t a r t o f c h e mo t h e r a p y . No s u b g r o u p i n a n y mo d a l i t y s h o we d a s i g n i f i c a n t l y i n c r e a s e d o v e r a l l s u r v i v a l c o mp a r e d t o o t h e
T a b l e 3 . Ch a r a c t e r i s t i c s o f P a t i e n t s Cl a s s i f i e d b y S u r v i v a l T i me
Changes of the values of each TM and SUV for TM responders
The changes of the values of TMs for all TM responders also indicated early decreases of the values within one
F i g u r e 3 . S u r v i v a l c u r v e s f o r p a t i e n t s c a t e g o r i z e d b y mo d a l i t y [ F DG-P E T ( A) , T M ( B ) a n d CT ( C) ] a n d f u r t h e r g r o u p e d b y b e s t t u mo r r e s p o n s e . P E T r e s p o n d e r s ( P R o r CR) s h o we d a s i g n i f ic a n t l y i n c r e a s e d o v e r a l l s u r v i v a l c o mp a r e d t o P E T n o n r e s p o n d e r s ( l o g r a n k t e s t ；p < 0 . 0 5 ) ( A) . T M r e s p o n d e r s ( P R o r CR) t e n d e d t o h a v e a n i n c r e a s e d o v e r a l l s u r v i v a l c o mp a r e d t o T M n o n r e s p o n d -
Presentation of cases
In case 12 (Fig. 5) , FDG-PET before the start of chemotherapy showed FDG uptake (SUV=5. 24) in the area of the pancreatic head (Fig. 5A) . One course after that, FDG-PET revealed slight attenuation of uptake (SUV=4.79; PET-SD) (Fig. 5B) . Depletion of the abnormal uptake (PET-CR) was achieved after six courses (Fig. 5C) . Meanwhile, as shown in Fig. 5D , serum levels of CA19-9, Span-1, and DU-PAN-2 were markedly decreased after 1 course (TM-PR), followed by normalization (TM-CR). In this instance TMs were more useful in predicting survival than FDG-PET. (17) , our data did not show a significant difference in survival between low and high SUV groups (Table 2) . Our data therefore indicates that contrary to some previous studies (13, 17) , SUV of the pancreatic lesion before treatment is not related to survival. This discrepancy may be due to differences in patient background: 7 stage III and 7 stage IV patients in the previous study (17) and 6 stage III and 13 stage IV patients in our study. One possible reason for the lack of association between SUV of
Discussion
The results of this study indicate that although FDG-PET is an important adjunct to TMs and CT for assessing treat
F i g u r e 4 . Ch a n g e s o f t h e v a l u e s o f e a c h T M a n d S UV f o r T M r e s p o n d e r s . T h a t o f T M wa s s h o wn d u r i n g 8 c o u r s e s , u n t i l wh i c h t h e b e s t t u mo r r e s p o n s e s , a s s e s s e d b y T M, we r e e x p r e s s e d , wh i l e t h a t o f S UV wa s s h o wn d u r i n g 1 2 c o u r s e s , u n t i l wh i c h t h e b e s t t u mo r r e s p o n s e s a s s e s s e d b y F DG-P E T we r e e x p r e s s e d . I n CA1 9 -9 , t h e v a l u e s o f c a s e 1 6 a r e i n d i c a t e d b y t h e r i g h t l o n g i t u d i n a l a x i s
；i n S p a n -1 , c a s e s 1 a n d 1 7 ；i n DU-P AN-2 , c a s e 1 7 . (12, (16) (17) (18) (19) (20) , while a few studies have shown that FDG-PET following therapy could not accurately predict survival (13) . Given that Rigo et al (21) (Fig. 3) as well as the changes of the values of each TM and SUV for TM responders (Fig. 4) (22) (23) (24) (25) (26) (27) . However, since these studies rely on limited numbers of patients and use varying definitions of CA19-9 response, further studies in a large cohort and using combination of some
F i g u r e 5 . Ca s e 1 2 F DG-P E T i ma g e s b e f o r e t h e s t a r t o f c h e mo t h e r a p y ( A) , a f t e r 1 c o u r s e ( B ) , a n d a f t e r 6 c o u r s e s ( C) , a n d t i me c o u r s e s o f T Ms ( D) . Ar r o ws i n d i c a t e F DG u p t a k e b y p a n c r e a t i c c a nc e r ( A) ( B ) .
TMs as the present study are needed. Although 
